Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Keratosis, Actinic 18Brain Neoplasms 18Glioblastoma 16Glioma 15Carcinoma, Basal Cell 7Astrocytoma 5Gliosarcoma 4Skin Neoplasms 3Precancerous Conditions 3Oligodendroglioma 3Mouth Neoplasms 3Carcinoma, Squamous Cell 3Squamous Intraepithelial Lesions 2Skull Base Neoplasms 2Sarcoma 2Pituitary Neoplasms 2Neoplasms 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Basal Cell Nevus Syndrome 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sezary Syndrome 1Oropharyngeal Neoplasms 1Nonmelanoma Skin Cancers 1Non-Melanoma Skin Cancer (NMSC) 1Neurofibromatosis 1 1Neurofibromatoses 1

Interventions

Cyclophosphamide 254fludarabine phosphate 165Cytarabine 160Methotrexate 128Busulfan 115Filgrastim 111fludarabine 102Peripheral Blood Stem Cell Transplantation 96Rituximab 94Antilymphocyte Serum 83Etoposide 81Cyclosporine 75Tacrolimus 74Mycophenolic Acid 73Whole-Body Irradiation 72Radiotherapy 70Melphalan 66Vincristine 55Dexamethasone 54Granulocyte Colony-Stimulating Factor 50Methylprednisolone 48Azacitidine 44Alemtuzumab 42Imatinib Mesylate 41Clofarabine 41sargramostim 40Idarubicin 36Daunorubicin 36Cord Blood Stem Cell Transplantation 36Mercaptopurine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia × Aminolevulinic Acid × Clear all
NCT00054171 2013-01-31

Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

Roswell Park Cancer Institute

Phase 2 Completed
1 enrolled
DermatologicLymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡